Association between exenatide use and incidence of Alzheimer's disease

INTRODUCTION: Recent developments suggest that insulin‐sensitizing agents used to treat type II diabetes (T2DM) may also prove useful in reducing the risk of Alzheimer's disease (AD). The objective of this study is to analyze the association between exenatide use among Medicare beneficiaries wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Bo, Zissimopoulos, Julie, Nadeem, Hasan, Crane, Matthew A., Goldman, Dana, Romley, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882542/
https://www.ncbi.nlm.nih.gov/pubmed/33614900
http://dx.doi.org/10.1002/trc2.12139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882542/
https://www.ncbi.nlm.nih.gov/pubmed/33614900
http://dx.doi.org/10.1002/trc2.12139

Ejemplares similares